ERBB2 and cardiomyopathy: In line with this, cardiomyopathy of mice with cardiac-specific deletion of HER2 might be rescued by the antiapoptotic Bcl-xL which supports the reversibility of cardiac toxicity associated with HER2 inhibition [105] by trastuzumab.